These findings suggest that Wnt/β-catenin and PI3K/AKT signaling work together to regulate PCSC stemness properties and targeting the pathways demonstrated potential therapeutic ways to eradicate prostate cancer. Here, AKT1 is linked to prostate carcinoma.